Raymond James Financial Services Advisors, Inc. Cybin Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$0.26 - $0.46 $1,298 - $2,296
-4,993 Reduced 5.17%
91,607 $24,000
Q1 2024

Apr 22, 2024
BUY
$0.3 - $0.46 $28,980 - $44,436
96,600 New
96,600 $39,000
Q1 2023

Apr 14, 2023
BUY
$0.3 - $0.56 $750 - $1,400
2,500 Added 23.58%
13,100 $4,000
Q4 2022

Feb 08, 2023
SELL
$0.26 - $0.64 $130 - $320
-500 Reduced 4.5%
10,600 $3,000
Q3 2022

Oct 25, 2022
BUY
$0.48 - $1.11 $5,328 - $12,321
11,100 New
11,100 $5,000

Others Institutions Holding CYBN

# of Institutions
11
Shares Held
185K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $2.07B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email